A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Medicinova Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 210,000 shares of MNOV stock, worth $367,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
210,000
Previous 230,400 8.85%
Holding current value
$367,500
Previous $334,000 9.58%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$1.28 - $1.57 $26,112 - $32,028
-20,400 Reduced 8.85%
210,000 $302,000
Q1 2024

May 13, 2024

BUY
$1.28 - $1.65 $72,064 - $92,895
56,300 Added 32.34%
230,400 $334,000
Q4 2023

Feb 13, 2024

BUY
$1.38 - $2.06 $33,810 - $50,470
24,500 Added 16.38%
174,100 $261,000
Q3 2023

Nov 14, 2023

BUY
$2.01 - $2.6 $5,426 - $7,020
2,700 Added 1.84%
149,600 $313,000
Q2 2023

Aug 11, 2023

BUY
$2.09 - $2.43 $5,225 - $6,075
2,500 Added 1.73%
146,900 $338,000
Q1 2023

May 12, 2023

BUY
$1.95 - $2.54 $4,095 - $5,334
2,100 Added 1.48%
144,400 $312,000
Q4 2022

Feb 13, 2023

SELL
$1.97 - $2.66 $14,775 - $19,950
-7,500 Reduced 5.01%
142,300 $292,000
Q3 2022

Nov 14, 2022

SELL
$2.1 - $2.6 $23,730 - $29,380
-11,300 Reduced 7.01%
149,800 $325,000
Q2 2022

Aug 12, 2022

BUY
$2.31 - $3.14 $26,334 - $35,796
11,400 Added 7.62%
161,100 $408,000
Q1 2022

May 13, 2022

BUY
$2.19 - $2.81 $16,206 - $20,794
7,400 Added 5.2%
149,700 $400,000
Q4 2021

Feb 11, 2022

BUY
$2.61 - $4.42 $34,713 - $58,786
13,300 Added 10.31%
142,300 $381,000
Q3 2021

Nov 12, 2021

SELL
$3.4 - $4.24 $20,740 - $25,864
-6,100 Reduced 4.52%
129,000 $489,000
Q2 2021

Aug 13, 2021

SELL
$3.76 - $5.14 $83,096 - $113,594
-22,100 Reduced 14.06%
135,100 $574,000
Q1 2021

May 13, 2021

SELL
$4.81 - $8.74 $226,550 - $411,654
-47,100 Reduced 23.05%
157,200 $794,000
Q4 2020

Feb 10, 2021

SELL
$5.03 - $6.31 $27,665 - $34,705
-5,500 Reduced 2.62%
204,300 $1.08 Million
Q3 2020

Nov 13, 2020

SELL
$4.67 - $11.0 $64,833 - $152,713
-13,883 Reduced 6.21%
209,800 $1.1 Million
Q2 2020

Aug 13, 2020

SELL
$3.06 - $7.06 $64,924 - $149,792
-21,217 Reduced 8.66%
223,683 $1.21 Million
Q1 2020

May 14, 2020

BUY
$2.9 - $6.97 $604,360 - $1.45 Million
208,400 Added 570.96%
244,900 $911,000
Q4 2019

Feb 13, 2020

BUY
$6.48 - $8.76 $236,520 - $319,740
36,500 New
36,500 $246,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $85.8M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.